Clinical trial
Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage…
NCT00309998 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00309998 |
|---|---|
| Title | Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer |
| Official title | Vinorelbine Plus Bevacizumab as First Line Therapy in Patients ≥ 70 Years of Age With Stage IIIB/IV Non-Squamous, Non-Small Cell Lung Cancer |
| Lead sponsor | University of Rochester, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological, Drug |
| Interventions | bevacizumab, vinorelbine tartrate |
| Enrollment | 50 |
| Start date | Sep 1, 2005 |
| Primary completion | May 1, 2007 |
| First posted | Apr 3, 2006 |
| Last update posted | Oct 29, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: